Assessment and Localisation of Response to Primary Systemic Therapy in Breast Cancer

被引：1
|
作者：
Noble, Frith [1 ]
机构：
[1] Wishaw Gen Hosp, Radiol Dept, 50 Netherton St, Wishaw ML2 0DP, Scotland
来源：
ULTRASOUND | 2009年 / 17卷 / 02期
关键词：
Primary Systemic Therapy; Ultrasound Guided Marking;
D O I：
10.1179/174313409X415819
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
Primary systemic therapy (PST) is used in non-metastatic breast cancer to decrease tumour size and reduce the extent of surgery. This article reviews imaging and surgical issues associated with the increasing use of PST in the management of breast cancer. The role of imaging, with a special focus on ultrasound, is evaluated.
引用
收藏
页码：80 / 84
页数：5
相关论文
共 50 条
  • [1] Unargued issues on the pathological assessment of response in primary systemic therapy for breast cancer
    Kuroi, K
    Toi, M
    Tsuda, H
    Kurosumi, M
    Akiyama, F
    BIOMEDICINE & PHARMACOTHERAPY, 2005, 59 : S387 - S392
  • [2] Primary systemic therapy of breast cancer
    Sachelarie, Irina
    Grossbard, Michael L.
    Chabha, Manjeet
    Feldman, Sheldon
    Ghesani, Munir
    Blum, Ronald H.
    ONCOLOGIST, 2006, 11 (06) : 574 - 589
  • [3] Issues in the assessment of the pathologic effect of primary systemic therapy for breast cancer.
    Kuroi K.
    Toi M.
    Tsuda H.
    Kurosumi M.
    Akiyama F.
    Breast Cancer, 2006, 13 (1) : 38 - 48
  • [4] Primary systemic therapy in breast cancer: clinical and molecular factors predictors of outcome and response
    Lerebours, F.
    PATHOLOGIE BIOLOGIE, 2006, 54 (04): : 209 - 214
  • [5] FDG-PET-CT in the early response evaluation for primary systemic therapy of breast cancer
    Tokes, Timea
    Torgyik, Laszlo
    Kulka, Janina
    Borka, Katalin
    Szasz, Attila Marcell
    Toth, Andrea
    Harsanyi, Laszlo
    Lengyel, Zsolt
    Gyoerke, Tamas
    Dank, Magdolna
    CENTRAL EUROPEAN JOURNAL OF MEDICINE, 2014, 9 (02): : 306 - 312
  • [6] Omitting surgery for early breast cancer showing clinical complete response to primary systemic therapy
    Shigematsu, Hideo
    Fujisawa, Tomomi
    Shien, Tadahiko
    Iwata, Hiroji
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2020, 50 (06) : 629 - 634
  • [7] Primary systemic therapy in breast cancer - an update for gynecologic oncologists
    Szekely, B.
    Szentmartoni, G.
    Kulka, J.
    Szasz, A. M.
    Langmar, Z.
    Dank, M.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2011, 32 (06) : 636 - 641
  • [8] Expression of cell cycle markers is predictive of the response to primary systemic therapy of locally advanced breast cancer
    Tímea Tőkés
    Anna-Mária Tőkés
    Gyöngyvér Szentmártoni
    Gergő Kiszner
    Lilla Madaras
    Janina Kulka
    Tibor Krenács
    Magdolna Dank
    Virchows Archiv, 2016, 468 : 675 - 686
  • [9] Expression of cell cycle markers is predictive of the response to primary systemic therapy of locally advanced breast cancer
    Tokes, Timea
    Tokes, Anna-Maria
    Szentmartoni, Gyongyver
    Kiszner, Gergo
    Madaras, Lilla
    Kulka, Janina
    Krenacs, Tibor
    Dank, Magdolna
    VIRCHOWS ARCHIV, 2016, 468 (06) : 675 - 686
  • [10] Is contrast-enhanced mammography (CEM) an alternative to MRI in assessing the response to primary systemic therapy of breast cancer?
    Sunen, Ines
    Barrado, Ana Isabel Garcia
    Ciria, Silvia Cruz
    Maroto, Julian Garcia
    Baneres, Belen Gros
    Mur, Carmen Garcia
    EUROPEAN JOURNAL OF RADIOLOGY, 2024, 170
12345